新生儿是最后一批被纳入治疗范畴的群体之一。 - Suppr

Suppr

超能文献

Newborns, one of the last therapeutic orphans to be adopted.

作者信息

Stiers Justin L, Ward Robert M

机构信息

Division of Neonatology, University of Utah, Salt Lake City.

出版信息

JAMA Pediatr. 2014 Feb;168(2):106-8. doi: 10.1001/jamapediatrics.2013.4604.

DOI:10.1001/jamapediatrics.2013.4604

PMID:24323280

Abstract

摘要

相似文献

Newborns, one of the last therapeutic orphans to be adopted.

JAMA Pediatr. 2014 Feb;168(2):106-8. doi: 10.1001/jamapediatrics.2013.4604.

Clinical trials in neonates: a therapeutic imperative.

Clin Pharmacol Ther. 2009 Dec;86(6):585-7. doi: 10.1038/clpt.2009.207.

Therapeutic orphans: European perspective.

Pediatrics. 1999 Sep;104(3 Pt 2):591-2.

Drug studies in newborns: a therapeutic imperative.

Clin Perinatol. 2012 Mar;39(1):11-23. doi: 10.1016/j.clp.2011.12.016. Epub 2012 Jan 21.

Off-label therapies for newborns. Miracles or mistakes?

AWHONN Lifelines. 2006 Apr-May;10(2):160-2. doi: 10.1111/j.1552-6356.2006.00029.x.

Therapeutic orphans.

Pediatrics. 1999 Sep;104(3 Pt 2):583-4.

Criteria supporting the study of drugs in the newborn.

Clin Ther. 2006 Sep;28(9):1385-98. doi: 10.1016/j.clinthera.2006.09.007.

American Academy of Pediatrics Committee on Drugs. "Therapeutic orphans" and the package insert.

Pediatrics. 1970 Nov;46(5):811-3.

[Use of intravenous cephaloridine in pediatrics].

Riv Clin Pediatr. 1968 Sep-Oct;81(5):937-45.

[Gentamicin in pediatrics].

G Ital Chemioter. 1969 Jan-Sep;16(1):233-9.

引用本文的文献

Pediatric flecainide pharmacogenomics: a roadmap to delivering precision-based care to pediatrics arrhythmias.

Front Pharmacol. 2024 Dec 16;15:1477485. doi: 10.3389/fphar.2024.1477485. eCollection 2024.

The Utility of Pharmacometric Models in Clinical Pharmacology Research in Infants.

Curr Pharmacol Rep. 2020 Oct;6(5):260-266. doi: 10.1007/s40495-020-00234-5. Epub 2020 Aug 18.

Parental perspectives long term after neonatal clinical trial participation: a survey.

Trials. 2020 Nov 2;21(1):907. doi: 10.1186/s13063-020-04787-0.

Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport.

Br J Clin Pharmacol. 2022 Oct;88(10):4285-4296. doi: 10.1111/bcp.14534. Epub 2020 Sep 15.

Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs.

Pharmaceutics. 2020 Jul 20;12(7):685. doi: 10.3390/pharmaceutics12070685.

Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials.

J Pediatr. 2020 Apr;219:243-249.e1. doi: 10.1016/j.jpeds.2019.09.060. Epub 2019 Nov 8.

Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators' perspective.

J Perinatol. 2019 Sep;39(Suppl 1):20-30. doi: 10.1038/s41372-019-0469-8.

Outcomes Research in Vulnerable Pediatric Populations.

J Neurosurg Anesthesiol. 2019 Jan;31(1):140-143. doi: 10.1097/ANA.0000000000000544.

The Need for Pediatric Drug Development.

J Pediatr. 2018 Jan;192:13-21. doi: 10.1016/j.jpeds.2017.08.011. Epub 2017 Sep 21.

Newborns still lack drug data to guide therapy.

Br J Clin Pharmacol. 2016 Dec;82(6):1410-1411. doi: 10.1111/bcp.13074. Epub 2016 Oct 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Newborns, one of the last therapeutic orphans to be adopted.

JAMA Pediatr. 2014 Feb;168(2):106-8. doi: 10.1001/jamapediatrics.2013.4604.

Clinical trials in neonates: a therapeutic imperative.

Clin Pharmacol Ther. 2009 Dec;86(6):585-7. doi: 10.1038/clpt.2009.207.

Therapeutic orphans: European perspective.

Pediatrics. 1999 Sep;104(3 Pt 2):591-2.

Drug studies in newborns: a therapeutic imperative.

Clin Perinatol. 2012 Mar;39(1):11-23. doi: 10.1016/j.clp.2011.12.016. Epub 2012 Jan 21.

Off-label therapies for newborns. Miracles or mistakes?

AWHONN Lifelines. 2006 Apr-May;10(2):160-2. doi: 10.1111/j.1552-6356.2006.00029.x.

Therapeutic orphans.

Pediatrics. 1999 Sep;104(3 Pt 2):583-4.

Criteria supporting the study of drugs in the newborn.

Clin Ther. 2006 Sep;28(9):1385-98. doi: 10.1016/j.clinthera.2006.09.007.

American Academy of Pediatrics Committee on Drugs. "Therapeutic orphans" and the package insert.

Pediatrics. 1970 Nov;46(5):811-3.

[Use of intravenous cephaloridine in pediatrics].

Riv Clin Pediatr. 1968 Sep-Oct;81(5):937-45.

[Gentamicin in pediatrics].

G Ital Chemioter. 1969 Jan-Sep;16(1):233-9.

引用本文的文献

Pediatric flecainide pharmacogenomics: a roadmap to delivering precision-based care to pediatrics arrhythmias.

Front Pharmacol. 2024 Dec 16;15:1477485. doi: 10.3389/fphar.2024.1477485. eCollection 2024.

The Utility of Pharmacometric Models in Clinical Pharmacology Research in Infants.

Curr Pharmacol Rep. 2020 Oct;6(5):260-266. doi: 10.1007/s40495-020-00234-5. Epub 2020 Aug 18.

Parental perspectives long term after neonatal clinical trial participation: a survey.

Trials. 2020 Nov 2;21(1):907. doi: 10.1186/s13063-020-04787-0.

Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport.

Br J Clin Pharmacol. 2022 Oct;88(10):4285-4296. doi: 10.1111/bcp.14534. Epub 2020 Sep 15.

Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs.

Pharmaceutics. 2020 Jul 20;12(7):685. doi: 10.3390/pharmaceutics12070685.

Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials.

J Pediatr. 2020 Apr;219:243-249.e1. doi: 10.1016/j.jpeds.2019.09.060. Epub 2019 Nov 8.

Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators' perspective.

J Perinatol. 2019 Sep;39(Suppl 1):20-30. doi: 10.1038/s41372-019-0469-8.

Outcomes Research in Vulnerable Pediatric Populations.

J Neurosurg Anesthesiol. 2019 Jan;31(1):140-143. doi: 10.1097/ANA.0000000000000544.

The Need for Pediatric Drug Development.

J Pediatr. 2018 Jan;192:13-21. doi: 10.1016/j.jpeds.2017.08.011. Epub 2017 Sep 21.

Newborns still lack drug data to guide therapy.

Br J Clin Pharmacol. 2016 Dec;82(6):1410-1411. doi: 10.1111/bcp.13074. Epub 2016 Oct 3.